Product
LX103
1 clinical trial
1 indication
Indication
X-linked retinoschisisClinical trial
An Open Label Dose Escalation Clinical Trial to Evaluate the Safety and the Efficacy of LX103 in Patients With X-Linked Retinoschisis (XLRS)Status: Recruiting, Estimated PCD: 2024-08-01